From Yahoo Finance: 2025-05-16 12:50:00

Shares in STAAR Surgical surged after announcing a $30m share buyback program to boost ownership and earnings per share despite revenue struggles in China. The company plans to repurchase outstanding common stock, driving shares up 5% to $19.25 and increasing its market cap to $906m. STAAR may buy back shares through various methods, including block purchases and structured agreements. The buyback will be funded from cash on hand and operations, as the company aims for sustainable, profitable growth. With its EVO product line of implantable lenses, STAAR aims to capture a share of the growing global intraocular lens device market, estimated at $5.6bn by 2034.



Read more at Yahoo Finance: STAAR Surgical plans $30m share buyback despite China market woes